From the Laboratory of Renal Physiopathology, Instituto Nacional de Cardiología Ignacio Chavez, CP 14080 Mexico City, Mexico and.
the Division of Renal Diseases and Hypertension, School of Medicine, University of Colorado, Aurora, Colorado 80045.
J Biol Chem. 2019 Mar 15;294(11):4272-4281. doi: 10.1074/jbc.RA118.006158. Epub 2019 Jan 16.
Dietary, fructose-containing sugars have been strongly associated with the development of nonalcoholic fatty liver disease (NAFLD). Recent studies suggest that fructose also can be produced via the polyol pathway in the liver, where it may induce hepatic fat accumulation. Moreover, fructose metabolism yields uric acid, which is highly associated with NAFLD. Here, using biochemical assays, reporter gene expression, and confocal fluorescence microscopy, we investigated whether uric acid regulates aldose reductase, a key enzyme in the polyol pathway. We evaluated whether soluble uric acid regulates aldose reductase expression both in cultured hepatocytes (HepG2 cells) and in the liver of hyperuricemic rats and whether this stimulation is associated with endogenous fructose production and fat accumulation. Uric acid dose-dependently stimulated aldose reductase expression in the HepG2 cells, and this stimulation was associated with endogenous fructose production and triglyceride accumulation. This stimulatory mechanism was mediated by uric acid-induced oxidative stress and stimulation of the transcription factor nuclear factor of activated T cells 5 (NFAT5). Uric acid also amplified the effects of elevated glucose levels to stimulate hepatocyte triglyceride accumulation. Hyperuricemic rats exhibited elevated hepatic aldose reductase expression, endogenous fructose accumulation, and fat buildup that was significantly reduced by co-administration of the xanthine oxidase inhibitor allopurinol. These results suggest that uric acid generated during fructose metabolism may act as a positive feedback mechanism that stimulates endogenous fructose production by stimulating aldose reductase in the polyol pathway. Our findings suggest an amplifying mechanism whereby soft drinks rich in glucose and fructose can induce NAFLD.
饮食中的果糖含量与非酒精性脂肪性肝病(NAFLD)的发生密切相关。最近的研究表明,果糖也可以通过肝脏中的多元醇途径产生,在肝脏中,它可能诱导肝脂肪堆积。此外,果糖代谢产生尿酸,尿酸与 NAFLD 高度相关。在这里,我们使用生化测定、报告基因表达和共聚焦荧光显微镜研究了尿酸是否调节醛糖还原酶,醛糖还原酶是多元醇途径中的关键酶。我们评估了可溶性尿酸是否调节培养的肝细胞(HepG2 细胞)和高尿酸血症大鼠肝脏中的醛糖还原酶表达,以及这种刺激是否与内源性果糖产生和脂肪堆积有关。尿酸在 HepG2 细胞中剂量依赖性地刺激醛糖还原酶的表达,这种刺激与内源性果糖产生和甘油三酯积累有关。这种刺激机制是由尿酸诱导的氧化应激和转录因子活化 T 细胞核因子 5(NFAT5)的刺激介导的。尿酸还放大了高葡萄糖水平刺激肝细胞甘油三酯积累的作用。高尿酸血症大鼠表现出肝醛糖还原酶表达升高、内源性果糖积累和脂肪堆积,黄嘌呤氧化酶抑制剂别嘌呤醇的共同给药显著减少了这些堆积。这些结果表明,果糖代谢过程中产生的尿酸可能作为一种正反馈机制,通过刺激多元醇途径中的醛糖还原酶来刺激内源性果糖产生。我们的研究结果表明,富含葡萄糖和果糖的软饮料可能通过诱导 NAFLD 产生放大机制。